News

Infecting people on purpose

18th October 2024

The power of human challenge studies in tackling infectious disease

Human ‘challenge trials’ entail risk but they could be our best protection against the next pandemic

28th May 2024

Next-generation vaccines in development today could help prevent an outbreak from becoming the next global crisis.

Imperial-led global human challenge consortium kick off ambitious 5-year project

24th April 2024

On 17-18 April, the MusiCC consortium convened at Imperial College London to kick off its ambitious 5-year project.

Virus background with disease cells and red blood cells

Healthy humans will be deliberately infected with Covid in bid to develop nasal spray vaccine

14th March 2024

A £44m project aims to develop next-generation treatments that reduce disease severity and block transmission.

Global human challenge consortium to push for next generation of vaccines

11th March 2024

An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.

Global consortium plans coordinated human challenge studies in hunt for transmission-blocking coronavirus vaccines

11th March 2024

An international consortium of researchers specialising in human challenge studies is embarking on a US$57 million project to develop advanced, virus-blocking coronavirus vaccines.

Updates from MusiCC

Keep up to date with the latest project news and research.

Infecting people on purpose

Human ‘challenge trials’ entail risk but they could be our best protection against the next pandemic

Imperial-led global human challenge consortium kick off ambitious 5-year project

Healthy humans will be deliberately infected with Covid in bid to develop nasal spray vaccine

Global human challenge consortium to push for next generation of vaccines

Global consortium plans coordinated human challenge studies in hunt for transmission-blocking coronavirus vaccines